DNMR OTC
Danimer Scientific, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
1Y: -91.5%
3Y: -99.5%
5Y: -100.0%
$0.35
Last traded 2025-12-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$47M
-12.3% ▼
5Y CAGR: +8.9%
Gross Profit
-$27M
-240.9% ▼
Operating Income
-$126M
+33.0% ▲
Net Income
-$155M
+13.5% ▲
EPS (Diluted)
$-1.52
+14.6% ▲
EBITDA
-$96M
+7.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $32M | $47M | $59M | $53M | $47M |
| YoY Growth | +6.2% | +46.3% | +24.1% | -9.4% | -12.3% |
| Cost of Revenue | $21M | $36M | $58M | $64M | $74M |
| Gross Profit | $11M | $11M | $884K | -$8M | -$27M |
| Gross Margin | 34.3% | 24.2% | 1.5% | -14.9% | -57.7% |
| R&D Expenses | $5M | $8M | $20M | $32M | $29M |
| SG&A Expenses | $16M | $19M | $80M | $82M | $69M |
| Operating Expenses | $22M | $27M | $100M | $180M | $99M |
| Operating Income | -$10M | -$16M | -$99M | -$187M | -$126M |
| Operating Margin | -32.2% | -33.2% | -169.2% | -352.2% | -269.1% |
| Interest Expense | $3M | $2M | $763K | $2M | $30M |
| Income Before Tax | -$15M | -$9M | -$73M | -$181M | -$155M |
| Tax Expense | $4M | $0 | -$13M | -$810K | $319K |
| Net Income | -$20M | -$9M | -$60M | -$180M | -$155M |
| Net Margin | -60.3% | -18.7% | -102.3% | -337.8% | -333.0% |
| EPS (Diluted) | $-0.41 | $-0.10 | $-0.65 | $-1.78 | $-1.52 |
| EBITDA | -$7M | -$2M | -$88M | -$103M | -$96M |
| Shares Outstanding | 48M | 85M | 93M | 101M | 102M |